Iboga, ibogaine, noribogaine & 18-MC
Page 4 (2000-2006)
Baumann et al. (2001). In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats. The Journal of Pharmacology of Experimental Therapeutics.
Szumlinski et al. (2001). Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties. Pharmacology, Biochemistry and Behavior.
MacInnes & Handley (2002). Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine. British Journal of Pharmacology.
Parke et al. (2002). Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine. Progress in Neuro-Psychopharmacology & Biological Psychiatry.
Kontrimaviciūte et al. (2006). Liquid chromatography-electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood. Application to a poisoning involving Tabernanthe iboga root. Journal of Chromatography.